Electronic cap prolongs survival from brain tumour
Treatment using an electronic cap boosts survival rates for people with an aggressive type of brain tumour, a clinical trial shows.
The treatment works by applying low frequency electricity to the brain through insulated electrodes that are placed on the patient’s shaved scalp using a cap.
These doses of electricity, called tumour-treating fields, interfere with the molecular mechanism in cancer cells that helps them divide.
The study, by the Northwestern University Feinberg School of Medicine in Chicago, covered 695 patients with glioblastoma who had undergone surgery to remove a tumour and radiotherapy.
Cap and drug
Two thirds of patients received the electronic cap treatment as well as the chemotherapy drug temozolomide. The remainder had only the drug.
Overall survival in patients who had the drug and the electronic therapy was 20.9 months on average, compared...
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Cancer Nursing Practice
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests